Aceclofenac use restricted

Further information
MHRA Drug Safety Update

The use of aceclofenac is now contraindicated in patients with certain established cardiovascular diseases, including ischaemic heart disease, peripheral arterial disease, cerebrovascular disease and congestive heart failure. Treatment with the drug should be initiated only after careful consideration of any significant cardiovascular risk factors.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

NICE overturns advice to increase steroid dose in children with asthma

NICE overturns advice to increase steroid dose in children with asthma

NICE has withdrawn its recommendation to quadruple...

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

New antibiotic guidance for leg ulcer infection

New antibiotic guidance for leg ulcer infection

NICE has issued guidance on antibiotic choices and...

New insertion site for Nexplanon following safety concerns

New insertion site for Nexplanon following safety concerns

The MHRA has amended its advice relating to the long-acting...